EDITORIALS

Positron Emission Tomography: Another Useful Test for Staging Esophageal Cancer

Charles J. Lightdale

JCO Sep 18 2000: 3199–3201. [Full Text] [PDF]

GASTROINTESTINAL CANCER
	Utility of Positron Emission Tomography for the Staging of Patients With Potentially Operable Esophageal Carcinoma
	P. Flamen, A. Lerut, E. Van Cutsem, W. De Wever, M. Peeters, S. Stroobants, P. Dupont, G. Bormans, M. Hiele, P. De Leyn, D. Van Raemdonck, W. Coosemans, N. Ectors, K. Haustermans, and L. Mortelmans
	JCO Sep 18 2000: 3202–3210. [Abstract] [Full Text] [PDF]

SARCOMAS
	Soft Tissue Leiomyosarcomas and Malignant Gastrointestinal Stromal Tumors: Differences in Clinical Outcome and Expression of Multidrug Resistance Proteins
	Boudewijn E. C. Plaat, Harry Hollema, Willemina M. Molenaar, Gerben H. Torn Broers, Justin Pijpe, Mirjam F. Mastik, Harald J. Hoekstra, Eva van den Berg, Rik J. Scheper, and Winette T. A. van der Graaf
	JCO Sep 18 2000: 3211–3220. [Abstract] [Full Text] [PDF]

LUNG CANCER
	Differential Frequencies of p16INK4a Promoter Hypermethylation, p53 Mutation, and K-ras Mutation in Exfoliative Material Mark the Development of Lung Cancer in Symptomatic Chronic Smokers
	M. Kersting, C. Friedl, A. Kraus, M. Behn, W. Pankow, and M. Schuermann
	JCO Sep 18 2000: 3221–3229. [Abstract] [Full Text] [PDF]

BREAST CANCER
	Activation (Tyrosine Phosphorylation) of ErbB-2 (HER-2/neu): A Study of Incidence and Correlation With Outcome in Breast Cancer
	A. D. Thor, S. Liu, S. Edgerton, D. Moore, II, K. M. Kasowitz, C. C. Benz, D. F. Stern, and M. P. DiGiovanna
	JCO Sep 15 2000: 3230–3239. [Abstract] [Full Text] [PDF]

GENITOURINARY CANCER
	Utilizing Predictions of Early Prostate-Specific Antigen Failure to Optimize Patient Selection for Adjuvant Systemic Therapy Trials
	Anthony V. D’Amico, Richard Whittington, S. Bruce Malkowicz, Yue Hui Wu, Ming-Hui Chen, Mark Hurwitz, Philip W. Kantoff, John E. Tomaszewski, Andrew A. Renshaw, Alan Wein, and Jerome P. Richie
	JCO Sep 18 2000: 3240–3246. [Abstract] [Full Text] [PDF]
	Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium
	J. Bellmunt, V. Guillem, L. Paz-Ares, J. L. González-Larriba, J. Carles, E. Batiste-Alentorn, A. Sáenz, M. López-Brea, A. Font, M. Nogué, R. Bastús, M. A. Climent, J. J. de la Cruz, J. Albanell, J. M. Banús, E. Gallardo, E. Diaz-Rubio, H. Cortés-Funes, and J. Baselga
	JCO Sep 18 2000: 3247–3255. [Abstract] [Full Text] [PDF]

PEDIATRIC ONCOLOGY
	High Survival Rate in Infant Acute Leukemia Treated With Early High-Dose Chemotherapy and Stem-Cell Support
	Fernando Marco, Encarna Bureo, Juan J. Ortega, Isabel Badell, Amparo Verdaguer, Ana Martínez, Arturo Muñoz, Luis Madero, Teresa Olivé, Josep Cubells, Victoria Castel, Ana Sastre, M. Soledad Maldonado, and Miguel A. Díaz
	JCO Sep 18 2000: 3256–3261. [Abstract] [Full Text] [PDF]
	Osteonecrosis as a Complication of Treating Acute Lymphoblastic Leukemia in Children: A Report From the Children’s Cancer Group
	Leonard A. Mattano, Jr, Harland N. Sather, Michael E. Trigg, and James B. Nachman
	JCO Sep 18 2000: 3262–3272. [Abstract] [Full Text] [PDF]
	Late Effects of Treatment in Survivors of Childhood Acute Myeloid Leukemia
	Wing Leung, Melissa M. Hudson, Donald K. Strickland, Sean Phipps, Deo K. Srivastava, Raul C. Ribeiro, Jeffrey E. Rubnitz, John T. Sandlund, Larry E. Kun, Laura C. Bowman, Bassem I. Razzouk, Prasad Mathew, Patricia Shearer, William E. Evans, and Ching-Hon Pui
	JCO Sep 18 2000: 3273–3279. [Abstract] [Full Text] [PDF]
	Health-Related Quality of Life in Survivors of Wilms’ Tumor and Advanced Neuroblastoma: A Cross-Sectional Study
	Ronald D. Barr, Dawn Chalmers, Sonja De Pauw, William Furlong, Sheila Weitzman, and David Feeny
	JCO Sep 18 2000: 3280–3287. [Abstract] [Full Text] [PDF]

PHASE I AND CLINICAL PHARMACOLOGY
	Pharmacokinetic and Pharmacodynamic Study of the Combination of Docetaxel and Topotecan in Patients With Solid Tumors
	William C. Zamboni, Merrill J. Egorin, David A. Van Echo, Roger S. Day, Barry R. Meisenberg, Sandra E. Brooks, L. Austin Doyle, Noble N. Nemieboka, Jason M. Dobson, Nancy S. Tait, and Katherine H. Tkaczuk
	JCO Sep 18 2000: 3288–3294. [Abstract] [Full Text] [PDF]

SUPPORTIVE CARE AND QUALITY OF LIFE
	How Are You Feeling? Who Wants To Know? Patients’ and Oncologists’ Preferences for Discussing Health-Related Quality-of-Life Issues
	S. B. Detmar, N. K. Aaronson, L. D. V. Wever, M. Muller, and J. H. Schornagel
	JCO Sep 15 2000: 3295–3301. [Abstract] [Full Text] [PDF]

REVIEW ARTICLES
	Systematic Overview of Cost-Utility Assessments in Oncology
	C. C. Earle, R. H. Chapman, C. S. Baker, C. M. Bell, P. W. Stone, E. A. Sandberg, and P. J. Neumann
	JCO Sep 18 2000: 3302–3317. [Abstract] [Full Text] [PDF]

CORRESPONDENCE

Survival Gain in Cost-Effectiveness Studies

Sabrina Trippoli, Monica Vaiani, Andrea Messori, Enrico Tendi, and Bruce E. Hillner

JCO Sep 18 2000: 3318. [Full Text] [PDF]

Optimal CD34+ Cell Dose in Autologous Peripheral-Blood Stem-Cell Transplantation

Orhan Sezer, Kurt Possinger, Bernd Metzner, Hans-Jochen Illiger, Mohammed Wattad, Wolfgang Heit, Harald Fuss, Wolfgang Schultze, Salvatore Siena, Roberta Schiavo, Andrea Sartore-Bianchi, and Paolo Pedrazzoli

JCO Sep 18 2000: 3319–3320. [Full Text]

Reduction of Distant Metastases in Head and Neck Cancer With Concomitant Chemotherapy

Bruce E. Brockstein and Branislav Jeremic

JCO Sep 18 2000: 3320–3321. [Full Text]

Evaluation: Continued Need for Randomized Trials

Roy A. Beveridge, David H. Regan, Grant Swanson, and Eva Stump

JCO Sep 18 2000: 3321–3322. [Full Text]

Interferon Does Not Prolong Progression-Free Survival After ProMACE-MOPP

Fernando Cabanillas, Richard I. Fisher, Michael LeBlanc, and Thomas Miller

JCO Sep 18 2000: 3322. [Full Text]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.